Antibiotics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 – 2030
CHAPTER 1. Industry Overview of Antibiotics Market
1.1. Definition and Scope
1.1.1. Definition of Antibiotics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Antibiotics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Antibiotics Market By Product Type
1.2.3. Antibiotics Market By Drug Origin
1.2.4. Antibiotics Market By Route of Administration
1.2.5. Antibiotics Market By Spectrum
1.2.6. Antibiotics Market By Distribution Channel
1.2.7. Antibiotics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Antibiotics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Antibiotics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Antibiotics Market By Product Type
5.1. Introduction
5.2. Antibiotics Revenue By Product Type
5.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Product Type, 2018-2030
5.2.2. Penicillin
5.2.2.1. Penicillin Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Cephalosporins
5.2.3.1. Cephalosporins Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Fluoroquinolones
5.2.4.1. Fluoroquinolones Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Macrolides
5.2.5.1. Macrolides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Carbapenems
5.2.6.1. Carbapenems Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.7. Aminoglycosides
5.2.7.1. Aminoglycosides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.8. Sulfonamides
5.2.8.1. Sulfonamides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.9. Other Product Types
5.2.9.1. Other Product Types Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Antibiotics Market By Drug Origin
6.1. Introduction
6.2. Antibiotics Revenue By Drug Origin
6.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Drug Origin, 2018-2030
6.2.2. Natural
6.2.2.1. Natural Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Semi-Synthetic
6.2.3.1. Semi-Synthetic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Synthetic
6.2.4.1. Synthetic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Antibiotics Market By Route of Administration
7.1. Introduction
7.2. Antibiotics Revenue By Route of Administration
7.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Route of Administration, 2018-2030
7.2.2. Oral
7.2.2.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Intravenous
7.2.3.1. Intravenous Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Others
7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. Antibiotics Market By Spectrum
8.1. Introduction
8.2. Antibiotics Revenue By Spectrum
8.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Spectrum, 2018-2030
8.2.2. Narrow-Spectrum Antibiotic
8.2.2.1. Narrow-Spectrum Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.3. Broad-spectrum Antibiotic
8.2.3.1. Broad-spectrum Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 9. Antibiotics Market By Distribution Channel
9.1. Introduction
9.2. Antibiotics Revenue By Distribution Channel
9.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030
9.2.2. Hospital Pharmacy
9.2.2.1. Hospital Pharmacy Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.3. Online Pharmacy
9.2.3.1. Online Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.4. Retail Pharmacy
9.2.4.1. Retail Pharmacy Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.5. Others
9.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 10. North America Antibiotics Market By Country
10.1. North America Antibiotics Market Overview
10.2. U.S.
10.2.1. U.S. Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
10.2.2. U.S. Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
10.2.3. U.S. Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
10.2.4. U.S. Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
10.2.5. U.S. Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.3. Canada
10.3.1. Canada Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
10.3.2. Canada Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
10.3.3. Canada Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
10.3.4. Canada Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
10.3.5. Canada Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.4. North America PEST Analysis
CHAPTER 11. Europe Antibiotics Market By Country
11.1. Europe Antibiotics Market Overview
11.2. U.K.
11.2.1. U.K. Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.2.2. U.K. Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.2.3. U.K. Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.2.4. U.K. Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.2.5. U.K. Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.3. Germany
11.3.1. Germany Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.3.2. Germany Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.3.3. Germany Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.3.4. Germany Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.3.5. Germany Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.4. France
11.4.1. France Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.4.2. France Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.4.3. France Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.4.4. France Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.4.5. France Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.5. Spain
11.5.1. Spain Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.5.2. Spain Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.5.3. Spain Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.5.4. Spain Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.5.5. Spain Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.6. Rest of Europe
11.6.1. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.6.2. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
11.6.3. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
11.6.4. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
11.6.5. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.7. Europe PEST Analysis
CHAPTER 12. Asia Pacific Antibiotics Market By Country
12.1. Asia Pacific Antibiotics Market Overview
12.2. China
12.2.1. China Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.2.2. China Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.2.3. China Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.2.4. China Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.2.5. China Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.3. Japan
12.3.1. Japan Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.3.2. Japan Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.3.3. Japan Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.3.4. Japan Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.3.5. Japan Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.4. India
12.4.1. India Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.4.2. India Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.4.3. India Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.4.4. India Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.4.5. India Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.5. Australia
12.5.1. Australia Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.5.2. Australia Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.5.3. Australia Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.5.4. Australia Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.5.5. Australia Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.6. South Korea
12.6.1. South Korea Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.6.2. South Korea Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.6.3. South Korea Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.6.4. South Korea Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.6.5. South Korea Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.7. Rest of Asia-Pacific
12.7.1. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.7.2. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
12.7.3. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
12.7.4. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
12.7.5. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.8. Asia Pacific PEST Analysis
CHAPTER 13. Latin America Antibiotics Market By Country
13.1. Latin America Antibiotics Market Overview
13.2. Brazil
13.2.1. Brazil Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.2.2. Brazil Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
13.2.3. Brazil Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.2.4. Brazil Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
13.2.5. Brazil Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.3. Mexico
13.3.1. Mexico Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.3.2. Mexico Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
13.3.3. Mexico Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.3.4. Mexico Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
13.3.5. Mexico Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.4. Rest of Latin America
13.4.1. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.4.2. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
13.4.3. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
13.4.4. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
13.4.5. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.5. Latin America PEST Analysis
CHAPTER 14. Middle East & Africa Antibiotics Market By Country
14.1. Middle East & Africa Antibiotics Market Overview
14.2. GCC
14.2.1. GCC Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.2.2. GCC Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
14.2.3. GCC Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.2.4. GCC Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
14.2.5. GCC Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.3. South Africa
14.3.1. South Africa Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.3.2. South Africa Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
14.3.3. South Africa Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.3.4. South Africa Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
14.3.5. South Africa Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.4. Rest of Middle East & Africa
14.4.1. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.4.2. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030
14.4.3. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030
14.4.4. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030
14.4.5. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
14.5. Middle East & Africa PEST Analysis
CHAPTER 15. Player Analysis Of Antibiotics Market
15.1. Antibiotics Market Company Share Analysis
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Mergers And Acquisition In Global Antibiotics Market
15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 16. Company Profile
16.1. Abbott Laboratories
16.1.1. Company Snapshot
16.1.2. Business Overview
16.1.3. Financial Overview
16.1.3.1. Revenue (USD Billion), 2021
16.1.3.2. Abbott Laboratories 2021 Antibiotics Business Regional Distribution
16.1.4. Product /Service and Specification
16.1.5. Recent Developments & Business Strategy
16.2. Allergan plc
16.3. Basilea Pharmaceutica Ltd.
16.4. Bayer Healthcare AG
16.5. F. Hoffmann-La Roche AG
16.6. GlaxoSmithKline PLC
16.7. Johnson & Johnson Inc.
16.8. Melinta Therapeutics
16.9. Merck & Co., Inc.
16.10. Novartis AG
16.11. Pfizer Inc.
16.12. Sanofi SA
16.13. Tetraphase Pharmaceuticals
Frequently Asked Questions
What is the size of global antibiotics market in 2021?
What is the size of global antibiotics market in 2021?
What is the CAGR of global antibiotics market during forecast period of 2022 to 2030?
The projected CAGR of antibiotics market during the analysis period of 2022 to 2030 is 4.6%.
Which are the key players operating in the market?
The prominent players of the global antibiotics market are Abbott Laboratories, Allergan plc, Basilea Pharmaceutica Ltd., Bayer Healthcare AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Inc., Melinta Therapeutics, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Tetraphase Pharmaceuticals.
Which region held the dominating position in the global antibiotics market?
Asia-Pacific held the dominating antibiotics during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for antibiotics during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global antibiotics market?
Rising incidence of infectious diseases, increasing development of advanced products, and advent of novel approaches for new antibiotics drives the growth of global antibiotics market.
Which product type held the maximum share in 2021?
Based on product type, penicillin segment is expected to hold the maximum share antibiotics market.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
